Here's why the Recce Pharmaceuticals (ASX:RCE) share price was on ice today

Recce shares are under the spotlight after an announcement by the company today

| More on:
A penguin on ice at sea.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Recce Pharmaceuticals Ltd (ASX: RCE) share price was halted today after the company made a key announcement.

Recce shares were trading 1.61% lower at 91.5 cents before being placed into a trading halt.

Let's get into the thick of it to understand what went down today.

What's happening with Recce Pharmaceuticals?

To understand what's led us to this point, we have to take a step back to the start of last month when Recce issued 10,000 ordinary shares upon the exercise of unlisted options.

Normally, if securities aren't listed, they can't be sold until 12 months after issue – but of course, there are exceptions to the rule. Companies can just submit a few forms to disclose the issue and sale of the shares, and everyone is on their way. It's routine practice on the ASX.

However, "due to an administrative oversight", the company forgot to lodge the cleansing notice forms that are required under section 708A(5)(e) of the Corporations Act 2001, when issuing and then on-selling its shares last month.

Under the legislature, companies are obliged to submit a cleansing notice within 5 business days of issuing shares in certain circumstances, such as when stock options are exercised.

The aim is to in effect 'cleanse' the market of any information that would have otherwise been undisclosed, that also may have a material impact on a share's price. It can also be used to lay false information to rest.

The company advised that it shortly intends to apply to the NSW Supreme Court for an extension on the time to lodge the cleansing notice. It intends to make the application on 11 October, according to the release.

Recce Pharmaceuticals share price snapshot

The Recce Pharmaceuticals share price has been swimming in a sea of red this year. It's fallen 15% in the last 12 months, 13% since January 1, and 11.5% in the past month.

These returns have lagged the S&P/ASX 200 index (ASX: XJO)'s return of around 20% this past year.

The author Zach Bristow has no positions in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Fallers

A woman with short brown hair and wearing a yellow top looks at the camera with a puzzled and shocked look on her face as the Westpac share price goes down for no reason today
Share Fallers

Why Australian Finance Group, Chalice, DroneShield, and ResMed are sinking today

These ASX shares are having a tough time on Thursday. But why?

Read more »

A young man goes over his finances and investment portfolio at home.
Growth Shares

1 ASX growth stock down 30% to buy right now

The market has reacted badly to this ASX 200 company's half-year result. This could be your chance to get in.

Read more »

A man sits in despair at his computer with his hands either side of his head, staring into the screen with a pained and anguished look on his face, in a home office setting.
Share Fallers

Why Flight Centre, Fortescue, Kelsian, and Neuren shares are dropping today

These ASX shares are being hit hard on Wednesday. But why?

Read more »

A woman with a sad face looks to be receiving bad news on her phone as she holds it in her hands and looks down at it.
Share Fallers

Why Brainchip, DGL, Weebit Nano, and Zip shares are dropping today

These ASX shares are being hit hard on Tuesday. But why?

Read more »

A man and a woman sit in front of a laptop looking fascinated and captivated.
Share Fallers

This ASX All Ords stock's founders just sold 40 million shares, and the stock dove 14%

This All Ords share's founders just cashed out $30 million.

Read more »

A young woman holds an open book over her head with a round mouthed expression as if to say oops as she looks at her computer screen in a home office setting with a plant on the desk and shelves of books in the background.
Share Fallers

Why Nanosonics, NIB, Santos, and TPG shares are falling today

These ASX shares are starting the week in the red.

Read more »

A worried man holds his head and look at his computer.
Share Fallers

Why Accent, Austal, Newmont, and Sandfire shares are plunging today

These ASX shares are ending the week in the red. But why?

Read more »

A young male investor wearing a white business shirt screams in frustration with his hands grasping his hair after ASX 200 shares fell rapidly today and appear to be heading into a stock market crash
Share Fallers

Why Clinuvel, Medibank, Sayona Mining, and Tabcorp shares are sinking today

These ASX shares are out of favour with investors on Thursday. But why?

Read more »